1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Association of ATG16L1 Variations with Clinical Phenotypes of Adult-Onset Still’s Disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Adult-onset Still’s disease (AOSD) is a rare autoinflammatory disease, which has elevated autophagosome levels regulated by autophagy-related gene (ATG) expression. We investigated the associations of ATG polymorphisms with AOSD susceptibility, clinical manifestations, and disease course. The six-candidate single-nucleotide polymorphisms (SNPs) involved in autophagy were genotyped using direct sequencing on samples from 129 AOSD patients and 129 healthy participants. The differentially expressed gene products were quantified using PCR and ELISA. Significant linkage disequilibrium was noted in three SNPs of autophagy-related 16-like 1 ( ATG16L1) gene (rs10210302, rs2241880, and rs1045100). Although the AA/CC/TT haplotype of ATG16L1 was not associated with the susceptibility of our AOSD patients compared with other haplotypes, those carrying this haplotype had lower mRNA expression levels of LC3-II, reflecting by autophagosome formation ( p = 0.026). Patients carrying AA/CC/TT haplotype also have a significantly higher proportion of skin rash and a lower proportion of arthritis compared with other haplotypes. The AA/CC/TT haplotype was significantly associated with systemic pattern (odds ratio, 3.25; 95% confidence interval, 1.15–9.14; p = 0.026). In summary, the AA/CC/TT haplotype encoded lower levels of autophagosome formation and was associated with a higher proportion of skin rash and systemic pattern of AOSD compared with other haplotypes.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production.

          Systems for protein degradation are essential for tight control of the inflammatory immune response. Autophagy, a bulk degradation system that delivers cytoplasmic constituents into autolysosomes, controls degradation of long-lived proteins, insoluble protein aggregates and invading microbes, and is suggested to be involved in the regulation of inflammation. However, the mechanism underlying the regulation of inflammatory response by autophagy is poorly understood. Here we show that Atg16L1 (autophagy-related 16-like 1), which is implicated in Crohn's disease, regulates endotoxin-induced inflammasome activation in mice. Atg16L1-deficiency disrupts the recruitment of the Atg12-Atg5 conjugate to the isolation membrane, resulting in a loss of microtubule-associated protein 1 light chain 3 (LC3) conjugation to phosphatidylethanolamine. Consequently, both autophagosome formation and degradation of long-lived proteins are severely impaired in Atg16L1-deficient cells. Following stimulation with lipopolysaccharide, a ligand for Toll-like receptor 4 (refs 8, 9), Atg16L1-deficient macrophages produce high amounts of the inflammatory cytokines IL-1beta and IL-18. In lipopolysaccharide-stimulated macrophages, Atg16L1-deficiency causes Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-dependent activation of caspase-1, leading to increased production of IL-1beta. Mice lacking Atg16L1 in haematopoietic cells are highly susceptible to dextran sulphate sodium-induced acute colitis, which is alleviated by injection of anti-IL-1beta and IL-18 antibodies, indicating the importance of Atg16L1 in the suppression of intestinal inflammation. These results demonstrate that Atg16L1 is an essential component of the autophagic machinery responsible for control of the endotoxin-induced inflammatory immune response.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Autophagy: process and function.

            Autophagy is an intracellular degradation system that delivers cytoplasmic constituents to the lysosome. Despite its simplicity, recent progress has demonstrated that autophagy plays a wide variety of physiological and pathophysiological roles, which are sometimes complex. Autophagy consists of several sequential steps--sequestration, transport to lysosomes, degradation, and utilization of degradation products--and each step may exert different function. In this review, the process of autophagy is summarized, and the role of autophagy is discussed in a process-based manner.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Genes (Basel)
                Genes (Basel)
                genes
                Genes
                MDPI
                2073-4425
                11 June 2021
                June 2021
                : 12
                : 6
                : 904
                Affiliations
                [1 ]Institute of Clinical Medicine, National Yang-Ming Chiao Tung University, Taipei 11221, Taiwan; wthung@ 123456vghtc.gov.tw
                [2 ]Department of Medical Education, Taichung Veterans General Hospital, Taichung 40705, Taiwan
                [3 ]Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Linkou, Taoyuan 33305, Taiwan; hungshueniu@ 123456gmail.com
                [4 ]Department of Medical Research, Taichung Veterans General Hospital, Taichung 40705, Taiwan; ymchen1@ 123456vghtc.gov.tw
                [5 ]School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan; dirac1982@ 123456vghtc.gov.tw
                [6 ]Rong Hsing Research Center for Translational Medicine & Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 40227, Taiwan; chiaweih@ 123456gmail.com (C.-W.H.); shc5555@ 123456hotmail.com (H.-H.C.)
                [7 ]Division of Allergy, Immunology, and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan
                [8 ]Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung 40705, Taiwan
                [9 ]Translational Medicine Laboratory, Rheumatology and Immunology Center, China Medical University Hospital, Taichung 40447, Taiwan
                [10 ]Rheumatology and Immunology Center, China Medical University Hospital, Taichung 40447, Taiwan
                [11 ]School of Medicine, China Medical University, Taichung 40447, Taiwan
                [12 ]Tsao-Tun Psychiatric Center, Ministry of Health and Welfare, Nantou 54249, Taiwan
                [13 ]Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli 35053, Taiwan
                Author notes
                [* ]Correspondence: dychen1957@ 123456mail.cmu.edu.tw (D.-Y.C.); thlan@ 123456nycu.edu.tw (T.-H.L.); Tel.: +886-4-2205-2121 (ext. 4628) (D.-Y.C.); +886-49-2550-800 (T.-H.L.); Fax: +886-4-2207-3812 (D.-Y.C.); +886-49-2564-184 (T.-H.L.)
                Author information
                https://orcid.org/0000-0001-6531-5538
                https://orcid.org/0000-0001-7593-3065
                https://orcid.org/0000-0002-7304-4587
                https://orcid.org/0000-0002-5468-1329
                https://orcid.org/0000-0002-2796-1026
                Article
                genes-12-00904
                10.3390/genes12060904
                8230810
                34208077
                bea3c2c4-ddd2-46e9-89f4-0a6d49d40c55
                © 2021 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( https://creativecommons.org/licenses/by/4.0/).

                History
                : 06 May 2021
                : 07 June 2021
                Categories
                Article

                atg16l1,haplotype,single-nucleotide polymorphism,autophagy,adult-onset still’s disease

                Comments

                Comment on this article